Dietrich Seidel

Author PubWeight™ 21.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events. Nat Clin Pract Cardiovasc Med 2009 1.31
2 Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003 1.25
3 Clinical relevance of circulating nucleosomes in cancer. Ann N Y Acad Sci 2008 1.23
4 Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation 2003 1.14
5 Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer. Clin Cancer Res 2004 1.08
6 Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma. Digestion 2008 0.99
7 Early and specific prediction of the therapeutic efficacy in non-small cell lung cancer patients by nucleosomal DNA and cytokeratin-19 fragments. Ann N Y Acad Sci 2006 0.93
8 Nucleosomes in serum of patients with early cerebral stroke. Cerebrovasc Dis 2005 0.92
9 Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock 2006 0.90
10 Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction. Am Heart J 2004 0.90
11 Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer: external validation of a prognostic score. Tumour Biol 2008 0.89
12 Nucleosomes in colorectal cancer patients during radiochemotherapy. Tumour Biol 2006 0.89
13 Nucleosomes in pancreatic cancer patients during radiochemotherapy. Tumour Biol 2005 0.88
14 Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins--reduction of circulating proinflammatory and procoagulatory markers. Atherosclerosis 2004 0.87
15 Nucleosomes as a new prognostic marker in early cerebral stroke. J Neurol 2007 0.87
16 Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: clinical results of a pilot study. Shock 2005 0.86
17 Serum cholesterol levels in neutropenic patients with fever. Clin Chem Lab Med 2002 0.81
18 Quantification of sirolimus by liquid chromatography-tandem mass spectrometry using on-line solid-phase extraction. Clin Chem Lab Med 2002 0.81
19 Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia. Transfus Apher Sci 2006 0.79
20 Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease. Transfus Apher Sci 2004 0.77
21 Pharmacokinetics of repinotan in healthy and brain injured animals. Biopharm Drug Dispos 2005 0.76
22 The efficacy and safety of the new heparin-induced extracorporeal low-density lipoprotein precipitation system (Plasmat Futura) in comparison with the currently used system (Plasmat Secura). Ther Apher Dial 2004 0.76
23 Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments. BMC Cancer 2006 0.76
24 The complex isotopologue space of glucose as a framework for the study of human intermediary metabolism. Isotopes Environ Health Stud 2015 0.75
25 Heparin-mediated extracorporeal LDL precipitation treating a peripheral arterial disease patient suffering from repeated postoperative bypass occlusion. Thromb Res 2005 0.75
26 Case reports on emergency treatment of cardiovascular syndromes through heparin-mediated low-density lipoprotein/fibrinogen precipitation: a new approach to augment cerebral and myocardial salvage. Ther Apher 2002 0.75
27 Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia. J Pediatr 2002 0.75
28 Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography. J Heart Lung Transplant 2005 0.75
29 [Atherogenesis: interplay between cholesterol, inflammation and coagulation]. Herz 2005 0.75